Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maksim Sergeyevich Eliseyev"'
Autor:
V G Barskova, Maksim Sergeyevich Eliseyev, I S Denisov, M E Eliseyeva, O A Belikov, G R Fadiyenko, F S Zharskaya, O P Polkovnikova, A N Kalyagin, M V Sklyanova, E A Shvetsova, L A Knyazeva, I M Marusenko, S E Myasoedova, E A Kozhevnikova, M N Petrova, T A Raskina, M V Koroleva, V V Tyrenko, A A Al-Nuvairakh, A G Khanov
Publikováno v:
Научно-практическая ревматология, Vol 50, Iss 6, Pp 15-18 (2012)
Objective: to study the rate of metabolic syndrome (MS) and its components among gout patients in different regions of the Russian Federation. Subjects and methods. This cross-sectional multicenter study enrolled 2277 gout patients, including 1963 (8
Externí odkaz:
https://doaj.org/article/5b09765dc8c343f08abc5b21d167cb2e
Publikováno v:
Современная ревматология, Vol 0, Iss 3, Pp 49-52 (2012)
The paper gives the results of an open-label trial of the Uralyt-U citrate used in 30 patients with gout and nephrolithiasis. In addition to rapid urine pH optimization, the use of the drug is shown to cause a reduction in the serum level of uric aci
Externí odkaz:
https://doaj.org/article/97340c7d62954f4e932753e282338aea
Publikováno v:
Современная ревматология, Vol 0, Iss 4, Pp 44-48 (2011)
Externí odkaz:
https://doaj.org/article/a6340a9dbef54d3794cf8cf5a3547ad3
Publikováno v:
Современная ревматология, Vol 0, Iss 4, Pp 35-38 (2011)
Externí odkaz:
https://doaj.org/article/6b53f91c1a344bcb9ef6995734a1bdc6
Publikováno v:
Современная ревматология, Vol 0, Iss 3, Pp 34-37 (2011)
The paper presents the results of a trial of the efficacy and safety of the nonsteroidal anti-inflammatory drug Amelotex® (international nonproprietary name meloxicam) in patients with pyrophosphate arthropathy (PA). One-month Amelotex® therapy is
Externí odkaz:
https://doaj.org/article/b5845afe7a174e5290652f494b114955
Publikováno v:
Современная ревматология, Vol 0, Iss 2, Pp 31-34 (2011)
The paper presents the results of a trial of the efficacy and safety of the nonsteroidal anti-inflammatory drug amelotex® (meloxicam) in patients with gonarthrosis. One-month meloxicam therapy is shown to have a good analgesic effect and tolerabilit
Externí odkaz:
https://doaj.org/article/45f9698993664cb0bb1dfb1b2b0c6bd4
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 3, Iss 1, Pp 22-26 (2011)